The Magazine for Sleep Professionals
Thursday, January 15, 2026
Recent research has elevated the management of obesity in patients with sleep disorders to a prominent position in clinical practice. Obesity has been capturing attention across social media, mainstream news, and even in cultural references such as South Park specials and Jimmy Kimmel’s 2023 Oscars commentary. This heightened focus underscores […]
Eli Lilly and Company announced the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the first and only prescription medicine for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity.1 Zepbound may help adults with moderate-to-severe obstructive sleep apnea and obesity improve their sleep disorder. It should be used with […]
By Nathan Costiuc, MSN, APRN, FNP-BC As the dark shadow of COVID-19 begins to lift, critically-important health concerns which had previously shrunk in significance are now returning to the limelight, chief among these being obesity. Unfortunately, the transition to low-level endemicity we hope for with SARS-CoV-2 is nowhere in sight […]
Weight loss in obese patients with obstructive sleep apnea (OSA) appears to improve sleep apnea primarily by reducing tongue fat, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Effect of Weight Loss on Upper Airway Anatomy and the Apnea Hypopnea Index: […]
The American Thoracic Society has published an official clinical guideline on the evaluation and management of obesity hypoventilation syndrome in the Society’s Aug. 1 American Journal of Respiratory and Critical Care Medicine. Obesity hypoventilation syndrome (OHS) is a breathing disorder that affects some people who are obese, causing them to have too much […]
